These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6136994)

  • 1. [Pharmacology of 1-phenylaminoethylamino-3-(phenoxy)propanol derivatives with beta-adrenergic action].
    Femmer K; Heer S; Poppe H
    Pharmazie; 1983 Jun; 38(6):409-14. PubMed ID: 6136994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-3,4-(3-3,4-dimethoxyphenethylamino-2-hydroxypropoxy)-phenyl- crotonic acid nitrile.HCl (Hoe 224), a beta-blocking agent with high beta 1-selectivity.
    Lindner E
    Arzneimittelforschung; 1984; 34(3):270-6. PubMed ID: 6145430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E; Murai T; Ishizaka Y; Sanai K
    Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Structure-activity relationship of phenoxyalkanolamine derivatives with selective beta 1-receptor blocking action].
    Femmer K
    Pharmazie; 1975 Oct; 30(10):638-42. PubMed ID: 687
    [No Abstract]   [Full Text] [Related]  

  • 5. [New beta-sympatholytic agents. Synthesis and pharmacological activity of isomeric benzthiazole and benzoxazole derivates (author's transl)].
    Franke A; Frickel FF; Gries J; Lehmann HD; Lenke D; Ohnsorge U
    Arzneimittelforschung; 1980; 30(11):1831-8. PubMed ID: 6109536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo assessment of the cardiovascular effects of the cardiotonic drug MDL 19205.
    Roebel LE; Dage RC; Cheng HC; Woodward JK
    J Cardiovasc Pharmacol; 1984; 6(1):43-9. PubMed ID: 6199610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacologic effects in combined use of oxyfedrine and beta-acetyldiogoxin].
    Stroman VF; Hempel R
    Arzneimittelforschung; 1975 Mar; 25(3):386-8. PubMed ID: 1174037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological properties of a new beta-blocking agent (1-isopropylamino-3-(2-methyl-3-nitrophenoxy)-propan-2-ol).
    Michalska Z; Robak J; Kostka-Trabka E; Grodzińska L; Górka Z; Gryglewski R
    Folia Biol (Krakow); 1974; 22(2):217-28. PubMed ID: 4151603
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction of cholecystokinin (CCK-8) with agonist and antagonist of beta-adrenergic receptors in circulatory system of diabetic rats.
    Wiśniewska RJ; Wiśniewski K
    Pol J Pharmacol; 1996; 48(3):293-7. PubMed ID: 9112665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta 1-selectivity of bisoprolol, a new beta-adrenoceptor antagonist, in anesthetized dogs and guinea pigs.
    Schliep HJ; Harting J
    J Cardiovasc Pharmacol; 1984; 6(6):1156-60. PubMed ID: 6084774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the clinical pharmacology of talinolol, a new beta 1-adrenoceptor blocking agent.
    Haustein KO; Fiehring H; Oltmanns G; Femmer K
    Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):465-70. PubMed ID: 43294
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiac effects of the novel pyridazinone derivative 6-[4-[2-[3-(5-chloro-2-cyanophenoxy)-2-hydroxypropylamino]- 2- methylpropylamino]phenyl]-4,5-dihydro-5-methyl-3(2H) pyridazinone monoethyl maleate and its metabolite in isolated heart preparations of guinea pigs and dogs.
    Ishimori T; Gotanda K; Sasaki T; Shinbo A; Asano H; Miyazawa K; Miyasaka K
    Arzneimittelforschung; 1994 May; 44(5):583-8. PubMed ID: 7912931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electromechanical effects of newly synthetized propafenone derivatives on isolated guinea-pig heart muscle preparations.
    Studenik C; Lemmens-Gruber R; Heistracher P; Ecker G; Maxl A; Fleischhacker W
    Arzneimittelforschung; 1996 Feb; 46(2):134-8. PubMed ID: 8720301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of beta-adrenoceptor blocking efficacy of two formulations of esmolol in vivo and in vitro.
    Tripathi CB; Bhattacharya P; Bhatt JD; Hemavathi KG
    Indian J Physiol Pharmacol; 1999 Apr; 43(2):255-8. PubMed ID: 10365322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of 4-(2-hydroxy-3-[(1-methyl-3-phenylpropyl)-amino]propoxy)benzeneacetamide (KF-4317).
    Kubo K; Nakamura J; Karasawa A; Shuto K; Nakamizo N
    Arzneimittelforschung; 1983; 33(7):926-31. PubMed ID: 6138045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivatives related to betaxolol with alpha- and beta-adrenergic activities.
    Leclerc G; Decker N; Schwartz J
    Arzneimittelforschung; 1985; 35(9):1357-67. PubMed ID: 2867769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular pharmacology of ASL-7022, a novel catecholamine. I. Inotropic, chronotropic and pressor actions.
    Gorczynski RJ
    J Pharmacol Exp Ther; 1982 Oct; 223(1):7-11. PubMed ID: 7120130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of a new beta-blocking drug, DL 071-IT, on the myocardial contractile state in the waking dog; a comparison with 9 known beta blockaders].
    Marchetti G; Di Francesco GF; Baldoli E
    Boll Soc Ital Cardiol; 1979; 24(9):1039-43. PubMed ID: 45253
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacodynamics of carteolol].
    Odenthal KP
    Arzneimittelforschung; 1983; 33(2a):281-5. PubMed ID: 6132609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of bufuralol, a beta-adrenoceptor antagonist with predominant beta 2-adrenoceptor agonistic activity, in the cat and the dog.
    Blaber LC; Burden DT; Eigenmann R; Gerold M
    J Cardiovasc Pharmacol; 1984; 6(1):165-75. PubMed ID: 6199600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.